In a total of 469 tumours of the patients who underwent a surgical resection, EGFR mutations were found in 136 cases (42.2%) with adenocarcinoma, in one case with large cell carcinoma, and in one case with pleomorphic carcinoma (Table 1). This evidence concerns the gene EGFR and neoplasm.